Publications

Authors:

Cherubini, Valentino; Fargalli, Andrea; Arnaldi, Claudia; Bassi, Marta; Bonfanti, Riccardo; Patrizia Bracciolini, Giulia; Cardella, Francesca; Dal Bo, Sara; Delvecchio, Maurizio; Di Candia, Francesca; Franceschi, Roberto; Maria Galassi, Sabrina; Gallo, Francesco; Graziani, Vanna; Iannilli, Antonio; Mameli, Chiara; Marigliano, Marco; Minuto, Nicola; Monti, Sara; Mozzillo, Enza; Pascarella, Filomena; Predieri, Barbara; Rabbone, Ivana; Roppolo, Rosalia; Schiaffini, Riccardo; Tiberi, Valentina; Tinti, Davide; Toni, Sonia; Scaramuzza, Andrea; Vestrucci, Benedetta; Gesuita, Rosaria

Title:

Glucometrics and device satisfaction in children and adolescents with type 1 diabetes using different treatment modalities: A multicenter real-world observational study

Year:

2024

Type of item:

Articolo in Rivista

Tipologia ANVUR:

Articolo su rivista

Language:

Inglese

Format:

Elettronico

Referee:

No

Name of journal:

Diabetes Research and Clinical Practice

ISSN of journal:

0168-8227

N° Volume:

210

Page numbers:

1-15

Keyword:

Children and adolescents; DIDS; Diabetes technology; Health related quality of life; Treatment modalities; Type 1 diabetes

Short description of contents:

Aims: To analyze metabolic outcomes, diabetes impact and device satisfaction in children and adolescents with type 1 diabetes in Italy who used different treatment modalities for diabetes care in a real-life context. Methods: In this multicenter, nationwide, cross-sectional study, 1464 participants were enrolled at a routine visit. The following treatment modalities were considered MDI + SMBG; MDI + CGM; Sensor Augmented Pump Therapy; predictive management of low glucose; Hybrid Closed Loop (HCL); Advanced Hybrid Closed Loop (AHCL). Health related quality of life was evaluated by the Italian version of the Diabetes Impact and Device Satisfaction Scale (DIDS) questionnaire. Results: Patients treated with AID systems were more likely to have HbA1c ≤ 6.5 %, higher percentage of time with glucose levels between 70 and 180 mg/dL, lower percentage of time with glucose levels above 180 mg/dL, higher device satisfaction, and reduced impact of diabetes. All the therapeutic modalities with respect to MDI + CGM, except for MDI + SMBG, contributed to increase the device satisfaction. HCL and AHCL respect to MDI + CGM were associated with lower diabetes impact. Conclusion: Real-life use of automated insulin delivery systems is associated with reduced type 1 diabetes impact, increased device satisfaction, and achievement of glycemic goals.

Product ID:

139044

Handle IRIS:

11562/1122607

Last Modified:

July 27, 2024

Bibliographic citation:

Cherubini, Valentino; Fargalli, Andrea; Arnaldi, Claudia; Bassi, Marta; Bonfanti, Riccardo; Patrizia Bracciolini, Giulia; Cardella, Francesca; Dal Bo, Sara; Delvecchio, Maurizio; Di Candia, Francesca; Franceschi, Roberto; Maria Galassi, Sabrina; Gallo, Francesco; Graziani, Vanna; Iannilli, Antonio; Mameli, Chiara; Marigliano, Marco; Minuto, Nicola; Monti, Sara; Mozzillo, Enza; Pascarella, Filomena; Predieri, Barbara; Rabbone, Ivana; Roppolo, Rosalia; Schiaffini, Riccardo; Tiberi, Valentina; Tinti, Davide; Toni, Sonia; Scaramuzza, Andrea; Vestrucci, Benedetta; Gesuita, Rosaria, Glucometrics and device satisfaction in children and adolescents with type 1 diabetes using different treatment modalities: A multicenter real-world observational study «Diabetes Research and Clinical Practice» , vol. 210 , 2024 , pp. 1-15

Consulta la scheda completa presente nel repository istituzionale della Ricerca di Ateneo